FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103270747> ?p ?o ?g. }

• W2103270747 endingPage "R24" @default.
• W2103270747 startingPage "R24" @default.
• W2103270747 abstract "Patients with active rheumatoid arthritis who had failed at least one disease-modifying anti-rheumatic drug (DMARD) were treated with adalimumab (ADA) in the ReAct study with the option to continue treatment for 5 years in ReAlise. The purpose of this study was to evaluate the long-term safety and effectiveness of ADA as prescribed from the first injection in ReAct to the last observation in ReAlise. Patients received ADA alone or in combination with DMARDs according to usual clinical care practices. Adverse events (AEs) were tabulated by five time windows after the first ADA injection. Effectiveness measures included achievement of low disease activity (LDA), defined as Simplified Disease Activity Index (SDAI) ≤11, or remission, (REM), defined as SDAI ≤3.3. Of the 6,610 ReAct patients, 3,435 (52%) continued in ReAlise. At baseline in ReAct, mean age was 54 years, mean DAS28 was 6.0 and mean HAQ DI was 1.64. The mean treatment duration was 1,016 days, representing 18,272 patient-years (PYs) of ADA exposure. Overall incidence rates of serious AEs and serious infections were 13.8 and 2.8 events (E)/100 PYs, respectively. Serious AEs occurred most frequently in the first 6 months and deceased thereafter. Standardised mortality ratio was 0.71 (95% CI 0.57 to 0.87) and standardised incidence ratio for malignancies was 0.64 (95% CI 0.53 to 0.76). LDA was achieved by 50% and REM by 21% of patients at last observation. Results of this large observational study of ADA in routine clinical practice were consistent with controlled trials, with no new safety concerns during a follow-up of more than 5 years. Effectiveness of ADA was maintained during long-term observation. NCT00448383 , NCT00234884" @default.
• W2103270747 created "2016-06-24" @default.
• W2103270747 creator A5039032334 @default.
• W2103270747 creator A5048909196 @default.
• W2103270747 creator A5051196993 @default.
• W2103270747 creator A5068419858 @default.
• W2103270747 creator A5074767050 @default.
• W2103270747 creator A5076851275 @default.
• W2103270747 creator A5079625006 @default.
• W2103270747 date "2014-01-01" @default.
• W2103270747 modified "2023-10-18" @default.
• W2103270747 title "Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study" @default.
• W2103270747 cites W1977445011 @default.
• W2103270747 cites W1985763670 @default.
• W2103270747 cites W1996389186 @default.
• W2103270747 cites W1997568521 @default.
• W2103270747 cites W2000905503 @default.
• W2103270747 cites W2006566716 @default.
• W2103270747 cites W2007486550 @default.
• W2103270747 cites W2009928292 @default.
• W2103270747 cites W2017281030 @default.
• W2103270747 cites W2046549669 @default.
• W2103270747 cites W2046628605 @default.
• W2103270747 cites W2071099746 @default.
• W2103270747 cites W2079590652 @default.
• W2103270747 cites W2100125044 @default.
• W2103270747 cites W2113696927 @default.
• W2103270747 cites W2115008314 @default.
• W2103270747 cites W2116048670 @default.
• W2103270747 cites W2123956703 @default.
• W2103270747 cites W2127696180 @default.
• W2103270747 cites W2132624379 @default.
• W2103270747 cites W2133038175 @default.
• W2103270747 cites W2133633410 @default.
• W2103270747 cites W2142500530 @default.
• W2103270747 cites W2143502358 @default.
• W2103270747 cites W2152368246 @default.
• W2103270747 cites W2152973730 @default.
• W2103270747 cites W2156140442 @default.
• W2103270747 cites W2158058290 @default.
• W2103270747 cites W2159106700 @default.
• W2103270747 cites W2166305732 @default.
• W2103270747 cites W2314052274 @default.
• W2103270747 cites W4295125684 @default.
• W2103270747 doi "https://doi.org/10.1186/ar4452" @default.
• W2103270747 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3979145" @default.
• W2103270747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24460746" @default.
• W2103270747 hasPublicationYear "2014" @default.
• W2103270747 type Work @default.
• W2103270747 sameAs 2103270747 @default.
• W2103270747 citedByCount "25" @default.
• W2103270747 countsByYear W21032707472014 @default.
• W2103270747 countsByYear W21032707472015 @default.
• W2103270747 countsByYear W21032707472016 @default.
• W2103270747 countsByYear W21032707472017 @default.
• W2103270747 countsByYear W21032707472018 @default.
• W2103270747 countsByYear W21032707472019 @default.
• W2103270747 countsByYear W21032707472020 @default.
• W2103270747 countsByYear W21032707472023 @default.
• W2103270747 crossrefType "journal-article" @default.
• W2103270747 hasAuthorship W2103270747A5039032334 @default.
• W2103270747 hasAuthorship W2103270747A5048909196 @default.
• W2103270747 hasAuthorship W2103270747A5051196993 @default.
• W2103270747 hasAuthorship W2103270747A5068419858 @default.
• W2103270747 hasAuthorship W2103270747A5074767050 @default.
• W2103270747 hasAuthorship W2103270747A5076851275 @default.
• W2103270747 hasAuthorship W2103270747A5079625006 @default.
• W2103270747 hasBestOaLocation W21032707471 @default.
• W2103270747 hasConcept C120665830 @default.
• W2103270747 hasConcept C121332964 @default.
• W2103270747 hasConcept C126322002 @default.
• W2103270747 hasConcept C197636746 @default.
• W2103270747 hasConcept C197934379 @default.
• W2103270747 hasConcept C198451711 @default.
• W2103270747 hasConcept C23131810 @default.
• W2103270747 hasConcept C2777575956 @default.
• W2103270747 hasConcept C2780132546 @default.
• W2103270747 hasConcept C61511704 @default.
• W2103270747 hasConcept C71924100 @default.
• W2103270747 hasConceptScore W2103270747C120665830 @default.
• W2103270747 hasConceptScore W2103270747C121332964 @default.
• W2103270747 hasConceptScore W2103270747C126322002 @default.
• W2103270747 hasConceptScore W2103270747C197636746 @default.
• W2103270747 hasConceptScore W2103270747C197934379 @default.
• W2103270747 hasConceptScore W2103270747C198451711 @default.
• W2103270747 hasConceptScore W2103270747C23131810 @default.
• W2103270747 hasConceptScore W2103270747C2777575956 @default.
• W2103270747 hasConceptScore W2103270747C2780132546 @default.
• W2103270747 hasConceptScore W2103270747C61511704 @default.
• W2103270747 hasConceptScore W2103270747C71924100 @default.
• W2103270747 hasIssue "1" @default.
• W2103270747 hasLocation W21032707471 @default.
• W2103270747 hasLocation W21032707472 @default.
• W2103270747 hasLocation W21032707473 @default.
• W2103270747 hasLocation W21032707474 @default.
• W2103270747 hasLocation W21032707475 @default.
• W2103270747 hasLocation W21032707476 @default.
• W2103270747 hasLocation W21032707477 @default.

• next